References
1a
Kleemann A.
Engel J. In
Pharmazeutische Wirkstoffe
Sucker H.
Fuchs P.
Thieme;
Stuttgart:
1987.
1b
Traxler P.
Trinks U.
Buchdunger E.
Mett H.
Meyer T.
Müller M.
Regenass U.
Rösel J.
Lydon N.
J. Med. Chem.
1995,
38:
2441
Reviews:
2a
Kleinman EF. In
Comprehensive Organic Synthesis
Vol. 2:
Trost BM.
Fleming I.
Heathcock CH.
Pergamon;
Oxford:
1991.
p.893
2b
Hiemstra H.
Speckamp WN. In
Comprehensive Organic Synthesis
Trost BM.
Fleming I.
Heathcock CH.
Pergamon;
Oxford:
1991.
Vol. 2.
p.1047
2c
Arend M.
Westermann B.
Risch N.
Angew. Chem., Int. Ed. Engl.
1998,
37:
1044 ; Angew. Chem. 1998, 110, 1097
2d
Kobayashi S.
Ishitani H.
Chem. Rev.
1999,
99:
1069
2e
Arend M.
Angew. Chem., Int. Ed.
1999,
38:
2873 ; Angew. Chem. 1999, 111, 3047
3a
Kober R.
Papadopoulos K.
Miltz W.
Enders D.
Steglich W.
Tetrahedron
1985,
41:
1693
3b
Münster M.
Steglich W.
Synthesis
1987,
223
3c
Miltz W.
Steglich W.
Synthesis
1990,
750
4a
Palomo C.
Oiarbide M.
Gonzáles-Rego MC.
Sharma AK.
García JM.
Gonzáles A.
Landa C.
Linden A.
Angew. Chem., Int. Ed.
2000,
39:
1063 ; Angew. Chem. 2000, 112, 1105
4b
Kanazawa AM.
Jean Noël D.
Greene AE.
J. Org. Chem.
1994,
59:
1238
5
Müller R.
Röttele H.
Henke H.
Waldmann H.
Chem.- Eur. J.
2000,
6:
2032
6
Giardina A.
Mecozzi T.
Petrini M.
J. Org. Chem.
2000,
65:
8277
7a
Kise N.
Ueda N.
J. Org. Chem.
1999,
64:
7511
7b
Mooiweer HH.
Ettema KWA.
Hiemstra H.
Speckamp WN.
Tetrahedron
1990,
46:
2991
7c
Shono T.
Kise N.
Sanda F.
Ohi S.
Yoshioka K.
Tetrahedron Lett.
1989,
30:
1253
7d
Brown DS.
Earle MJ.
Fairhurst RA.
Heaney H.
Papageorgiou G.
Wilkins RF.
Eyley S.
Synlett
1990,
619
8a
Ferraris D.
Young B.
Dudding T.
Drury WJ. III.
Lectka T.
Tetrahedron
1999,
55:
8869 ; and literature cited therein
8b
Juhl K.
Gathergood N.
Jørgensen KA.
Angew. Chem., Int. Ed. Engl.
2001,
40:
2995 ; Angew. Chem. 2001, 113, 3083
9
Enders D.
Schunk S.
Org. Lett.
2001,
3:
3177
10
Enders D.
Adam J.
Klein D.
Otten T.
Synlett
2000,
1371
11a
Enders D.
Ward D.
Adam J.
Raabe G.
Angew. Chem., Int. Ed. Engl.
1996,
35:
981 ; Angew. Chem. 1996, 108, 1059
11b
Enders D.
Oberbörsch S.
Adam J.
Synlett
2000,
644
12
Enders D.
Otten T.
Synlett
1999,
747
13a
Engberts JBFN.
Strating J.
Recueil
1965,
84:
942
13b
Engberts JBFN.
Strating J.
Recueil
1964,
83:
733
13c
Pearson WH.
Lindbeck AC.
Kampf JW.
J. Am. Chem. Soc.
1993,
115:
2622
13d
Ballini R.
Petrini M.
Tetrahedron
1999,
40:
4449
14
Ireland RE.
Müller RH.
Willard AK.
J. Am. Chem. Soc.
1976,
98:
2868
15
Asymmetric Mannich Reactions:
Method A: 1.2 Equiv potassium hydride was added to a solution of 1.1 equiv carbamate 3 in dry CH2Cl2 (5 mL/mmol 3) under argon. After stirring for 1 h at r.t. the reaction mixture was cooled to -78 °C. After addition of 1.1-1.5 equiv TiCl4 (1.0 N in CH2Cl2) and stirring for 20 min at this temperature the solution was cooled to -90 °C. 1 equiv Silyl enol ether 2 in dry CH2Cl2 (1 mL/mmol 2) was added dropwise. The reaction mixture was stirred for 75 min at
-90 °C → -78 °C, then quenched with a saturated solution of NaHCO3, extracted with CH2Cl2 and dried over MgSO4. After evaporation of the solvent, the crude Mannich adducts 4 were purified by flash chromatography (SiO2, n-pentane/Et2O).
Method B: A solution of 1.1 equiv carbamate 3 in dry CH2Cl2 (5 mL/mmol) under argon was cooled to -78 °C. After addition of 1.1-1.5 TiCl4 (1.0 N in CH2Cl2) and stirring for 20 min at this temperature the solution was cooled to -90 °C. 1 equiv Silyl enol ether 2 in dry CH2Cl2 (1 mL/mmol 2) was added dropwise. (Further procedure see Method A).
Analytical data of compound (S,R,S)-4a:
[α]D
24 = -93.6 (CHCl3, c = 0.50). 1H NMR [400 MHz, (CD3)2 CO]: δ = 0.08 (s, 3 H, SiCH
3), 0.16 (s, 3 H, SiCH
3), 0.90 (d, 3 H, J = 6.8, CHCH
3), 0.91 (d, 3 H, J = 6.9, CH
3CHCH3), 0.93 (d, 3 H, J = 6.9, CH3CHCH
3), 0.94 (s, 3 H, CH
3CCH3), 0.95 (s, 3 H, CH3CCH
3), 1.40 (s, 9 H, OC(CH
3)3), 1.77 (sept, 1 H, J = 6.9, CH3CHCH3), 2.77 (m, 1 H, CHHC6H4Br), 3.07 (qd, 1 H, J = 6.9, 3.3, CHCH3), 3.13-3.24 (m, 2 H, CHHC6H4Br, SiCH), 4.70 (d, 1 H, J = 8.3, CHNH), 6.00 (m, 1 H, NH), 6.66 (m, 2 H, CH-Ph), 7.10-7.47 (m, 7 H, CH-C6H4Br, m/pCH-Ph) ppm. 13C NMR [100 MHz, (CD3)2CO]: δ = -3.7 (SiCH3), -2.0 (SiCH3), 13.3 (CH3), 18.9 (CH3CHCH3), 19.1 (CH3CHCH3), 21.5 (CH3CCH3), 21.8 (CH3CCH3), 25.7 (CH3
CCH3), 28.5 (OC(CH3)3), 33.7 (CH2C6H4Br), 34.9 (CH3
CHCH3), 47.4 (SiCH), 53.1 (CHCH3), 56.5 (CHNH), 79.1 (OC(CH3)3), 120.0 (C-C6H4Br), 127.2 (pCH-Ph), 127.4 (CH-Ph), 128.4 (mCH-Ph), 131.2 (CH-C6H4Br), 132.0 (CH-C6H4Br), 140.4 (C-Ph), 142.1 (C-C6H4Br), 155.6 (OC=O), 211.8 (C=O) ppm. MS (CI, isobutane): m/z (%): 591(35), 590 (100, M+ + 1), 589(33), 588(90), 534(47), 533(28), 532(48), 529(8), 526(6), 512(6), 511(22), 510(59), 504(7), 502(6), 491(14), 490(50), 489(14), 488(46), 454(15), 447(20), 446(12), 411(11), 410(36), 368(7), 305(7), 206(20), 150(9), 106(20). Anal. Calcd. for C31H46NO3SiBr (588.70): C, 63.25; H, 7.88; N, 2.38. Found: C, 63.22; H, 7.75; N, 2.30.
16
For removal of the dimethylthexylsilyl group see ref. 11b. Analytical data of compound (R,S)-5a:
[α]D
24 = -29.0 (CHCl3, c = 0.50). 1H NMR (400 MHz, CDCl3): δ = 1.14 (d, 3 H, J = 6.9, CHCH
3), 1.41 (s, 9 H, OC(CH
3)3), 2.15-2.70 (m, 4 H, CH
2CH
2), 3.05 (m, 1 H, CHCH3), 4.81 (m, 1 H, CHNH), 5.87 (m, 1 H, NH), 6.87 (d, 2 H, J = 8.3, CH-Ph), 7.10-7.35 (m, 7 H, CH-C6H4Br, m/pCH-Ph) ppm. 13C NMR (100 MHz, CDCl3): δ = 15.1 (CH3), 28.3 (OC(CH3)3), 28.4 (CH2C6H4Br), 44.2 (CH2CO), 51.0 (COCHCH3), 57.0 (CHNH), 79.4 (OC(CH3)3), 119.6 (C-C6H4Br), 125.9 (pCH-Ph), 127.1 (CH-Ph), 128.4 (mCH-Ph), 129.8 (CH-C6H4Br), 131.2 (CH-C6H4Br), 139.6 (C-Ph), 141.0 (C-C6H4Br), 155.3 (OC=O), 213.2 (C=O) ppm. MS (EI, 70 eV): m/z (%): 447 (1, M+), 390(23), 389(21), 211(4), 207(4), 206(34), 184(4), 182(4), 170(13), 169(13), 151(9), 150(100), 147(4), 134(4), 132(7), 118(15), 117(9), 107(6), 106(70), 104(9), 77(5), 57(59). Anal. Calcd. for C23H28NO3Br (446.38): C 61.89, H 6.23, N 3.14. Found: C, 61.82; H, 6.30; N, 3.00.
17 All new compounds showed suitable spectroscopic data (NMR, MS, IR) and correct elemental analyses.